TALPHERA, INC. Restricted Cash, Current
TALPHERA, INC. (TLPH) had Restricted Cash, Current of $0 as of 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2024-03-06
- 2023-12-31: Restricted Cash, Current $0.00.
- 2023-09-30: Restricted Cash, Current $0.00.
- 2023-06-30: Restricted Cash, Current $0.00.
- 2023-03-31: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-06 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-12-31 | $5.00M 10-K · filed 2024-03-06 |
| 2022-09-30 | $5.00M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.00M 10-Q · filed 2022-08-11 |
| 2021-12-31 | $0.00 8-K · filed 2023-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |